Skip to content

Neurotrophin-Enriched Extracellular Vesicles Delivery System for Efficient Blood−Brain Barrier Translocation and Neuroprotection

Oct 2026 · ACS Applied Nano Materials · 0 citations · 67 references

TL;DR

These findings provide valuable insights into a neurovascular unit-derived extracellular vesicle system that not only targets the brain and crosses the BBB but also offers a forward-looking strategy for neuroprotection in the mitigation of other neurodegenerative diseases.

Abstract

This study addresses the formidable challenge presented by the blood−brain barrier (BBB) in the treatment of neurological diseases by introducing a biomimetic delivery system utilizing extracellular vesicles, which efficiently crosses the BBB without requiring additional targeting moieties. Inspired by the neurotrophic function of the astrocytes, specifically the release of growth factors like Glial-Derived Neurotrophic Factor (GDNF), we harnessed extracellular vesicles from primary astrocytes (ADE), naturally enriched with GDNF (26.18 ± 4.15 pcg/mL), and subsequently coated them onto mesoporous silica nanoparticles loaded with donepezil (DNP), a model drug to formulate ADE_MSN-DNP. The system proposed BBB permeation and cellular uptake, significantly reduced oxidative stress in a Caenorhabditis elegans model, and increased plasma half-life and brain distribution in C57BL/6 male mice (6−8 months old), as estimated through LC−MS/MS and optical live imaging using Coumarin-6 as a fluorescent probe. The enhanced targeting and efficacy are proposed to be primarily attributed to intact GDNF and the intrinsic homing ability of the extracellular vesicles that facilitate efficient delivery of DNP. These findings provide valuable insights into a neurovascular unit-derived extracellular vesicle system that not only targets the brain and crosses the BBB but also offers a forward-looking strategy for neuroprotection in the mitigation of other neurodegenerative diseases.

View source

Similar papers

Oct 2026

Intranasal Delivery of Engineered Neural Stem Cell-Derived Extracellular Vesicles Enables Targeted Delivery of Liraglutide to the Brain

Liraglutide (LG), a glucagon-like peptide-1 (GLP-1) receptor agonist, is approved for treating type 2 diabetes mellitus and as a weight loss drug in obesity. Recently, LG has emerged as a promising neuroprotective agent in suppressing neuroinflammation by modulating disease-associated inflammatory pathways in various...

Sourabh Mehta, Suresh Thangudu, Golnaz Haghverdi et al. · 0 citations
Sep 2026

A Brain-Targeted Nanozyme System for Alleviating Poststroke Neuroinflammation via Synergistic Antioxidant and Anti-inflammatory Mechanisms.

Ischemic stroke (IS) is severely aggravated by oxidative stress and neuroinflammation, while the blood-brain barrier (BBB) poses a major obstacle to effective therapy. Herein, we developed a brain-targeted nanozyme system (TLNP@Pt/Fe3O4) by encapsulating Pt/Fe3O4 nanozymes into T7 peptide-modified lipid nanoparticles....

Bo-Yang Wei, Yu Wu, Jia-Ming Zhou et al. · 0 citations
Open access Oct 2026

Targeted Delivery of Mdivi-1 via RVG-Functionalized Extracellular Vesicles for Mitochondrial Protection in Ischemic Stroke

Background Mitochondrial dysfunction is a major contributor to neuronal death following ischemic stroke, promoting excessive reactive oxygen species (ROS) production, inflammation and apoptotic signaling that exacerbate secondary brain injury. Mdivi-1 has demonstrated mitochondrial and neuroprotective potential; howeve...

Jian Xiao, Jie Yu, Ying-Jie Song et al. · 0 citations
Open access Oct 2026

Self-Assembling Betulinic Acid and Squalene Nanoparticles Enhance the Blood−Brain Barrier Reinforcing Activity of Trehalose

Trehalose, a natural disaccharide with well-established neuroprotective effects in the central nervous system (CNS), has been extensively investigated for its anti-inflammatory, protein-stabilizing, and autophagy-inducing activities. Despite these beneficial CNS effects, its potential impact on the blood−brain barrie...

Veronica Fontanini, Arianna Amenta, Alice Maiocchi et al. · 0 citations
Oct 2026

Targeting the Immune-Neurovascular Interface to Ameliorate Pericyte Dysfunction with a Multifunctional Peptide-Drug Conjugate Nanoprodrug for Multiple Sclerosis Therapy.

This work identifies pericytes as a central regulatory node and establishes a pericyte-targeted PDC nanoplatform for durable MS treatment, highlighting its translational potential as a complementary strategy to conventional immunomodulatory approaches.

Yong-Kang Mu, Kai-Chao Wen, Ling-Ling Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.